Cybele Ghossein
Overview
Explore the profile of Cybele Ghossein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nishi L, Langman C, Ghossein C
Kidney Med
. 2020 Aug;
1(6):405-406.
PMID: 32734222
No abstract available.
12.
Joslin B, Langman C, Nishi L, Ghossein C
BMC Nephrol
. 2020 Jan;
21(1):8.
PMID: 31928529
Background: Transfer from a pediatric to an adult medical setting is associated with many barriers. Additionally, there are little data on patients' assessment of the transition process itself. 3 years...
13.
Krueger K, Ison M, Ghossein C
Am J Kidney Dis
. 2019 Oct;
75(3):417-425.
PMID: 31585683
Infection is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD), including those receiving maintenance dialysis or with a kidney transplant. Although responses to vaccines...
14.
Butler E, Baron M, Fogo A, Frech T, Ghossein C, Hachulla E, et al.
Arthritis Rheumatol
. 2019 Jan;
71(6):964-971.
PMID: 30614663
Objective: To generate a core set of items to develop classification criteria for scleroderma renal crisis (SRC) using consensus methodology. Methods: An international, multidisciplinary panel of experts was invited to...
15.
ODonnell J, Ghossein C, Rhodes N, Peng J, Lertharakul T, Pham C, et al.
J Infect Chemother
. 2017 Jan;
23(5):326-332.
PMID: 28109741
Vancomycin is one of the most commonly utilized antibiotics in US hospitals. It remains the drug of choice for the treatment of serious infections caused by methicillin-resistant Staphylococcus aureus. For...
16.
Xiao X, Ghossein C, Tortajada A, Zhang Y, Meyer N, Jones M, et al.
Mol Immunol
. 2016 Aug;
77:89-96.
PMID: 27490940
C3 glomerulopathy (C3G) is an ultra-rare complement-mediated renal disease characterized histologically by the predominance of C3 deposition within in the glomerulus. Familial cases of C3G are extremely uncommon and offer...
17.
Ghossein C, Varga J, Fenves A
Curr Rheumatol Rep
. 2015 Dec;
18(1):5.
PMID: 26711696
Scleroderma renal crisis (SRC) is an uncommon complication of systemic sclerosis. Despite the advent of angiotensin-converting inhibitor therapy, SRC remains a life-threatening complication. Recent studies have contributed to a better...
18.
Coyne D, Goldberg S, Faber M, Ghossein C, Sprague S
Clin J Am Soc Nephrol
. 2014 Jun;
9(9):1620-6.
PMID: 24970869
Background And Objectives: Calcitriol is used to treat secondary hyperparathyroidism in patients with CKD. Paricalcitol is less calcemic and phosphatemic in preclinical studies and in some trials in dialysis patients,...
19.
Benken S, Lizza B, Yamout H, Ghossein C
Am J Health Syst Pharm
. 2013 Nov;
70(23):2105-9.
PMID: 24249760
Purpose: The management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration (CVVH) is reported. Summary: A 46-year-old African-American woman with New York Heart Association class IV,...
20.
Loo A, Neely M, Anderson E, Ghossein C, McLaughlin M, Scheetz M
Antimicrob Agents Chemother
. 2013 Sep;
57(12):5854-9.
PMID: 24018264
Ceftazidime is a broad-spectrum cephalosporin with high-level activity against a variety of Gram-negative pathogens, including Pseudomonas aeruginosa. Improved outcomes are associated with cumulative percentages of a 24-h period that the...